Literature DB >> 32673151

Melatonin protects INS-1 pancreatic β-cells from apoptosis and senescence induced by glucotoxicity and glucolipotoxicity.

Yu Hee Lee1, Hye Sook Jung2, Min Jeong Kwon1, Jung Eun Jang1, Tae Nyun Kim1, Soon Hee Lee1, Mi-Kyung Kim1,2, Jeong Hyun Park1,2.   

Abstract

INTRODUCTION: Melatonin is a hormone known as having very strong anti-oxidant property. Senescence is a biological state characterized by the loss of cell replication and the changes consisting of a pro-inflammatory phenotype, leading to Senescence Associated Secretory Phenotype (SASP) which is now regarded as one of the fundamental processes of many degenerative diseases. Increased cell division count induces cell senescence via DNA damage in response to elevated Reactive Oxygen Species (ROS). We wanted to test whether melatonin could reduce apoptosis and stress induced premature pancreatic β-cell senescence induced by glucotoxicity and glucolipotoxicity. MATERIALS AND
METHOD: Cultured rodent pancreatic β-cell line (INS-1 cell) was used. Glucotoxicity (HG: hyperglycemia) and glucolipotoxicity (HGP: hyperglycemia with palmitate) were induced by hyperglycemia and the addition of palmitate. The degrees of the senescence were measured by SA-β-Gal and P16lnk4A staining along with the changes of cell viabilities, cell cycle-related protein and gene expressions, endogenous anti-oxidant defense enzymes, and Glucose Stimulated Insulin Secretion (GSIS), before and after melatonin treatment.
RESULTS: Cultured INS-1 cells in HG and HGP conditions revealed accelerated senescence, increased apoptosis, cell cycle arrest, compromised endogenous anti-oxidant defense, and impaired glucose-stimulated insulin secretion. Melatonin decreased apoptosis and expressions of proteins related to senescence, increase the endogenous anti-oxidant defense, and improved glucose-stimulated insulin secretion.
CONCLUSION: Melatonin protected pancreatic β-cell from apoptosis, decreased expressions of the markers related to the accelerated senescence, and improved the biological deteriorations induced by glucotoxicity and glucolipotoxicity.

Entities:  

Keywords:  Melatonin; Senescence; glucolipotoxicity; glucotoxicity; pancreatic β-cell

Year:  2020        PMID: 32673151      PMCID: PMC7527021          DOI: 10.1080/19382014.2020.1783162

Source DB:  PubMed          Journal:  Islets        ISSN: 1938-2014            Impact factor:   2.694


  40 in total

Review 1.  Oxidative and endoplasmic reticulum stress in β-cell dysfunction in diabetes.

Authors:  Sumaira Z Hasnain; Johannes B Prins; Michael A McGuckin
Journal:  J Mol Endocrinol       Date:  2015-11-17       Impact factor: 5.098

Review 2.  Molecular tools to study melatonin pathways and actions.

Authors:  Jean A Boutin; Valérie Audinot; Gilles Ferry; Philippe Delagrange
Journal:  Trends Pharmacol Sci       Date:  2005-08       Impact factor: 14.819

Review 3.  Update on melatonin receptors: IUPHAR Review 20.

Authors:  Ralf Jockers; Philippe Delagrange; Margarita L Dubocovich; Regina P Markus; Nicolas Renault; Gianluca Tosini; Erika Cecon; Darius P Zlotos
Journal:  Br J Pharmacol       Date:  2016-08-08       Impact factor: 8.739

Review 4.  Melatonin transport into mitochondria.

Authors:  Juan C Mayo; Rosa M Sainz; Pedro González-Menéndez; David Hevia; Rafael Cernuda-Cernuda
Journal:  Cell Mol Life Sci       Date:  2017-08-21       Impact factor: 9.261

Review 5.  Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance.

Authors:  Rüdiger Hardeland
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

6.  Melatonin prevents mitochondrial dysfunction and insulin resistance in rat skeletal muscle.

Authors:  Bruno G Teodoro; Flavia G Baraldi; Igor H Sampaio; Lucas H M Bomfim; André L Queiroz; Madla A Passos; Everardo M Carneiro; Luciane C Alberici; Ramon Gomis; Fernanda G Amaral; José Cipolla-Neto; Michel B Araújo; Tanes Lima; Sérgio Akira Uyemura; Leonardo R Silveira; Elaine Vieira
Journal:  J Pineal Res       Date:  2014-07-22       Impact factor: 13.007

Review 7.  Melatonin: therapeutic and clinical utilization.

Authors:  A Altun; B Ugur-Altun
Journal:  Int J Clin Pract       Date:  2007-02-13       Impact factor: 2.503

8.  Increased Melatonin Signaling Is a Risk Factor for Type 2 Diabetes.

Authors:  Tiinamaija Tuomi; Cecilia L F Nagorny; Pratibha Singh; Hedvig Bennet; Qian Yu; Ida Alenkvist; Bo Isomaa; Bjarne Östman; Johan Söderström; Anu-Katriina Pesonen; Silja Martikainen; Katri Räikkönen; Tom Forsén; Liisa Hakaste; Peter Almgren; Petter Storm; Olof Asplund; Liliya Shcherbina; Malin Fex; João Fadista; Anders Tengholm; Nils Wierup; Leif Groop; Hindrik Mulder
Journal:  Cell Metab       Date:  2016-05-12       Impact factor: 27.287

9.  Association between oxidative stress and telomere length in Type 1 and Type 2 diabetic patients.

Authors:  D Ma; W Zhu; S Hu; X Yu; Y Yang
Journal:  J Endocrinol Invest       Date:  2013-07-15       Impact factor: 4.256

10.  4-Nerolidylcatechol: apoptosis by mitochondrial mechanisms with reduction in cyclin D1 at G0/G1 stage of the chronic myelogenous K562 cell line.

Authors:  Polyana Lopes Benfica; Renato Ivan de Ávila; Bruna Dos Santos Rodrigues; Alane Pereira Cortez; Aline Carvalho Batista; Marilisa Pedroso Nogueira Gaeti; Eliana Martins Lima; Kênnia Rocha Rezende; Marize Campos Valadares
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

View more
  4 in total

1.  Melatonin protects against nonylphenol caused pancreatic β-cells damage through MDM2-P53-P21 axis.

Authors:  Shasha Tao; Youjing Yang; Yayun Fan; Kaimiao Chu; Jiaojiao Sun; Qianqian Wu; Aiqing Wang; Jianmei Wan; Hailin Tian
Journal:  Toxicol Res (Camb)       Date:  2022-04-10       Impact factor: 2.680

Review 2.  Diabetes and SARS-CoV-2-Is There a Mutual Connection?

Authors:  Anna P Jedrzejak; Edyta K Urbaniak; Jadwiga A Wasko; Natalia Ziojla; Malgorzata Borowiak
Journal:  Front Cell Dev Biol       Date:  2022-06-13

Review 3.  Control of Mesenchymal Stromal Cell Senescence by Tryptophan Metabolites.

Authors:  Kenneth K Wu
Journal:  Int J Mol Sci       Date:  2021-01-12       Impact factor: 5.923

Review 4.  Targeting Host Defense System and Rescuing Compromised Mitochondria to Increase Tolerance against Pathogens by Melatonin May Impact Outcome of Deadly Virus Infection Pertinent to COVID-19.

Authors:  Dun-Xian Tan; Ruediger Hardeland
Journal:  Molecules       Date:  2020-09-25       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.